Hybio Pharmaceutical Co., Ltd. (SHE:300199)

Hybio Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 28, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	23,768	11,385	11,994	15,527	11,138	5,917
Market Cap Growth	52.53%	-5.08%	-22.75%	39.41%	88.22%	14.66%
Enterprise Value	24,926	13,122	13,710	17,024	12,784	7,126
Last Close Price	26.91	12.89	13.58	17.58	12.61	6.65
PE Ratio	-	-	-	-	361.52	-
Forward PE	-	9.21	9.21	9.21	9.21	9.21
PS Ratio	26.89	19.29	27.80	22.05	15.13	8.20
PB Ratio	32.07	19.07	15.31	11.97	6.76	3.53
P/TBV Ratio	53.52	39.92	22.37	15.44	8.43	4.48
P/FCF Ratio	171.59	232.96	-	-	-	-
P/OCF Ratio	82.28	69.12	-	982.28	71.02	123.30
PEG Ratio	-	1.00	1.00	1.00	1.00	1.00
EV/Sales Ratio	28.20	22.23	31.78	24.17	17.37	9.87
EV/EBITDA Ratio	78.68	115.59	-	-	-	-
EV/EBIT Ratio	146.40	-	-	-	-	-
EV/FCF Ratio	179.95	268.51	-	-	-	-
Debt / Equity Ratio	2.04	3.01	2.59	1.39	1.09	1.16
Debt / EBITDA Ratio	4.78	15.72	-	-	-	-
Debt / FCF Ratio	10.93	36.79	-	-	-	-
Asset Turnover	0.28	0.19	0.13	0.19	0.19	0.17
Inventory Turnover	1.71	1.44	1.52	1.12	1.58	0.91
Quick Ratio	0.31	0.14	0.36	0.52	1.28	0.74
Current Ratio	0.48	0.33	0.48	0.71	1.55	0.95
Return on Equity (ROE)	-3.23%	-26.10%	-49.56%	-25.30%	1.71%	-31.16%
Return on Assets (ROA)	3.32%	-0.64%	-6.74%	-3.03%	-4.26%	-7.79%
Return on Capital (ROIC)	4.42%	-0.78%	-7.85%	-3.48%	-4.78%	-8.64%
Return on Capital Employed (ROCE)	10.00%	-	-	-	-	-
Earnings Yield	-0.07%	-1.52%	-4.28%	-2.39%	0.28%	-10.30%
FCF Yield	0.58%	0.43%	-0.71%	-1.12%	-0.38%	-3.31%
Payout Ratio	-	-	-	-	375.37%	-
Buyback Yield / Dilution	17.64%	2.00%	-0.42%	14.09%	-11.21%	-0.19%
Total Shareholder Return	-	2.00%	-0.42%	14.09%	-11.21%	-0.19%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.